Stratec SE
Research Stratec SE (SBS.DE) on Bullrun: market cap EUR 263.78M, dividend yield 2.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerSBS.DE
- ExchangeXETRA
- CountryGermany
- SectorHealthcare
- IndustryMedical Devices
- CurrencyEUR
- Market capEUR 263.78M
- Dividend yield2.6%
- Financial periodQ2 2026
- RevenueEUR 59.11M
- Net incomeEUR 4.16M
- Free cash flowEUR 4.90M
- Gross margin25.8%
Valuation Snapshot
latest market cap is EUR 263.78M; dividend yield is 2.6%.
Peer valuation comparison
Latest dividend yield is 2.56% versus a Healthcare sector median of 1.84% (39.1% above).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-04 | EUR 263.78M | n/a | 2.8% | 0.6 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.6 EUR, yield 2.6%.
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Stratec SE's market cap?
Stratec SE's market capitalization is EUR 263.78M.
Does Stratec SE pay a dividend?
Stratec SE has a dividend yield of 2.6%.
What does Stratec SE do?
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.